TipRanks
Go Ultimate55% OFF

William Lis Insider Profile

4 Followers

William Lis, Director at Zai Lab, holds 41.93K shares in Zai Lab (Ticker: ZLAB), holds 53.52K shares in Jasper Therapeutics (Ticker: JSPR), holds 204.45K shares in Portola Pharma (Ticker: PTLA).

William Lis's Trading History

ZLAB
Zai Lab
Aug 13, 2026DirectorUninformative Sell212.65K$925.42K
JSPR
Jasper Therapeutics
Oct 13, 2023DirectorUninformative Sell6.77K$27.83K
PTLA
Portola Pharma
Jun 08, 2018―Uninformative Sell231.16K$3.69M
EIDX
Eidos Therapeutics
――――

You May Also Like

William Lis insider profile FAQ

What is the percentage of profitable transactions made by William Lis?
The percentage of profitable transactions made by William Lis is 50%.
What is the average return per transaction made by William Lis?
The average return per transaction made by William Lis is -28.80%.
What stocks does William Lis hold?
William Lis holds: ZLAB, PTLA, EIDX, JSPR stocks.
What was William Lis’s latest transaction?
William Lis’s latest transaction was an Uninformative Sell of $212.65K.
What was William Lis's most profitable transaction?
William Lis’s most profitable transaction was an Informative Sell of PTLA stock on April 30, 2015. The return on the trade was 33.40%.
What is William Lis's role in Zai Lab?
William Lis's role in Zai Lab is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.